Develop Enterprise Partners Venture Capital 
socalTECH
AUGUST 19, 2010
San Diego-based venture capital firm Enterprise Partners is one of the firms in a $39M, Series E funding round for Mountain View-based Complete Genomics , Complete Genomics said today. Complete Genomics is developing a DNA sequencing product which competes against products from Illumina.
socalTECH
AUGUST 23, 2013
San Diego-based XIFIN , which develops cloud-based financial software for the healthcare industry, has acquired Irvine-based PathCentral , a developer of software for the pathology community, the company announced Thursday afternoon. XIFIN''s investors include Boulder Ventures, Enterprise Partners, and Windward Ventures.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
socalTECH
AUGUST 10, 2021
Solana Beach-based Wildfire Systems, which develops technology used for powering reward and loyalty programs, has raised $15M in a Series A funding, according to the company. Wildfire is led by founder and CEO Jordan Glazier, who is a technology vet, having served at eBay and also been the CEO of Eventful.
socalTECH
OCTOBER 1, 2009
A quick analysis by socalTECH of our tracking of venture capital deals in Southern California finds that there was around $879M in venture funding activity here in Q3. The biggest are for venture activity in the quarter was Biopharmaceuticals, which was $299.13M of the quarterly total.
socalTECH
AUGUST 14, 2018
Santa Barbara-based AxiaMed , which is developing healthcare payments technology, said late Tuesday afternoon that it has raised $12.4M The funding was led by Health Enterprise Partners (HEP), and also included Nashville Capital Network and other existing investors. in a funding round.
socalTECH
MAY 7, 2012
San Diego-based Celladon , a biopharmaceuticals firm developing a genetically targeted enzyme replacement therapy which helps in the treatment of late-stage, heart failure, has raised $53M in a second close of a funding round, the firm said today. and Venrock. and Venrock. READ MORE>>.
socalTECH
FEBRUARY 16, 2012
La Jolla-based Celladon Corporation , a developer of biopharmaceuticals targeting cardiovascular disease, said Wednesday afternoon that it has raised $43M in a financing round. Celladon is developing a compound for treating heart failure.
Expert insights. Personalized for you.
154 
Let's personalize your content